Intrauterine Fetal Demise (IUFD)

01Pathophysiology

Intrauterine fetal death is defined as the death of a fetus at or beyond 20 weeks of gestation (or weighing 350 grams or more if gestational age is unknown). Before 20 weeks, the event is classified as a miscarriage or spontaneous abortion, and this distinction is a frequently tested boundary.

The underlying mechanism varies by gestational age and etiology, but the final common pathway is cessation of fetal cardiac activity due to one or more insults. In many cases, the process begins with uteroplacental insufficiency, where the placenta fails to deliver adequate oxygen and nutrients to the fetus. Chronic hypoxia leads to progressive acidemia, redistribution of fetal blood flow (brain-sparing effect), and eventually irreversible myocardial failure. This is why many stillborn fetuses show evidence of intrauterine growth restriction on prior ultrasounds.

In cases driven by placental abruption, the mechanism is acute. Premature separation of the placenta from the uterine wall causes sudden loss of gas exchange, leading to rapid fetal asphyxia. The mother may present with vaginal bleeding, abdominal pain, and a rigid or tender uterus, but in concealed abruption, external bleeding may be absent while the fetus deteriorates.

Umbilical cord accidents (true knots, cord prolapse, nuchal cord with compression) interrupt blood flow mechanically. These events are often unpredictable and may account for a portion of otherwise unexplained fetal deaths.

Fetal infections cause death through direct tissue damage, myocarditis, hydrops fetalis, or severe anemia. Parvovirus B19 is particularly high-yield because it targets erythroid precursor cells, causing profound fetal anemia and nonimmune hydrops fetalis, which can progress to cardiac failure and death.

A critical concept for the exam is what happens when the dead fetus is retained in utero for a prolonged period (typically beyond 3 to 4 weeks). The retained dead fetal tissue releases thromboplastin into the maternal circulation, which activates the extrinsic coagulation cascade and consumes clotting factors and platelets. This produces a consumptive coagulopathy (DIC), manifesting with prolonged PT/PTT, decreased fibrinogen, elevated D-dimer, and thrombocytopenia. This is the reason why timely delivery is emphasized and why serial coagulation monitoring is essential once IUFD is diagnosed.

02Classification and Clinical Manifestation

Clinical Manifestation By Stage

03Diagnostic Workup

The workup proceeds in two phases. Phase one is confirming the diagnosis. When a mother reports decreased or absent fetal movement, the first step in any clinical setting is Doppler auscultation to assess for fetal heart tones. However, absence of heart tones on handheld Doppler alone is not sufficient to declare fetal death because of technical limitations (maternal habitus, early gestational age, device error). The diagnosis must be confirmed by real-time obstetric ultrasound demonstrating absence of fetal cardiac activity. This is the standard of care, and a vignette that describes absent Doppler tones should prompt you to select "confirm with ultrasound" as the next best step.

Phase two begins once IUFD is confirmed. The goals shift to (1) assessing maternal safety, particularly coagulation status, and (2) investigating the cause of fetal death. A baseline coagulation panel including fibrinogen, PT, PTT, D-dimer, and platelet count should be drawn immediately. If the fetus has been dead for a prolonged period or the duration is uncertain, this becomes urgent because DIC risk rises progressively. Fibrinogen is the single most useful marker: a level below 200 mg/dL is concerning, and below 100 mg/dL indicates severe DIC requiring correction before delivery.

The etiologic workup (Kleihauer-Betke, TORCH, thrombophilia panel, metabolic labs) is performed to guide counseling for future pregnancies. Fetal autopsy combined with placental pathology is the most informative investigation and should be offered to all parents, though consent is required.

04Management and Treatment

Delivery is the definitive treatment and should not be delayed unnecessarily, though it is not a surgical emergency (unlike placental abruption with hemodynamic instability, which would require emergent cesarean). The timing of delivery depends on maternal stability. If coagulation is normal, induction can proceed promptly. If DIC is present, correction of coagulopathy takes priority before proceeding with delivery to avoid catastrophic hemorrhage.

For pregnancies at 20 to 28 weeks, the cervix is often unfavorable and the uterus is less responsive to oxytocin, making misoprostol the preferred agent. It acts as a prostaglandin E1 analog that softens the cervix and stimulates uterine contractions. Pretreatment with mifepristone (a progesterone receptor antagonist) 24 to 48 hours before misoprostol shortens the induction-to-delivery interval and is recommended when available.

For pregnancies beyond 28 weeks, both oxytocin and low-dose misoprostol are options. The critical caution here is in women with a prior uterine scar (previous cesarean section). In these patients, misoprostol carries an increased risk of uterine rupture, and many guidelines recommend using oxytocin preferentially or using very low doses of misoprostol (25 mcg) with close monitoring. A vignette that features a woman with IUFD at 34 weeks and a prior cesarean scar is testing whether you recognize this contraindication.

Expectant management (waiting for spontaneous labor) is generally discouraged beyond a short period because of the cumulative risk of DIC. If the patient strongly desires to wait, serial coagulation studies (at least weekly fibrinogen levels) are mandatory.

An important exam point: cesarean delivery is rarely indicated for IUFD because the fetus is already dead, and subjecting the mother to major abdominal surgery provides no fetal benefit while adding maternal risk. Cesarean would be reserved for situations where vaginal delivery is contraindicated (e.g., complete placenta previa, prior classical cesarean incision).

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students lose points on IUFD questions is by jumping to delivery before confirming the diagnosis with ultrasound. A vignette describing absent fetal heart tones on Doppler is deliberately testing whether you will select "obtain obstetric ultrasound" rather than "begin induction of labor." The handheld Doppler finding is a screening observation, not a definitive diagnosis.

The second major trap involves prolonged fetal retention and DIC. The vignette will describe a woman who was diagnosed with fetal demise days to weeks ago and now presents with easy bruising, oozing from IV sites, or abnormal bleeding. Students who do not recognize this as consumptive coagulopathy from retained dead fetal tissue will miss the need to correct the coagulopathy before or during delivery. Selecting "proceed with induction" without addressing the DIC is the intended wrong answer.

A third trap targets the distinction between IUFD and missed abortion. If the gestational age is given as 18 or 19 weeks with absent cardiac activity, the answer is missed abortion, not IUFD. Test-writers use borderline gestational ages to test whether you know the 20-week cutoff.

Finally, remember that cesarean delivery is almost never the correct answer for IUFD unless there is a clear maternal indication (e.g., complete previa, prior classical incision). The vignette may tempt you with urgency language, but the fetus is already dead, and vaginal delivery is strongly preferred to minimize maternal morbidity. The core competency being tested across all IUFD questions is this: confirm before you act, assess maternal safety (coagulation), deliver vaginally, and investigate the cause.